11/19
08:30 am
hcwb
HCW Biologics Enters into $4.0 Million Warrant Inducement Priced At-the-Market Under Nasdaq Rules
High
Report
HCW Biologics Enters into $4.0 Million Warrant Inducement Priced At-the-Market Under Nasdaq Rules
11/18
07:25 am
hcwb
HCW Biologics Announces Initiation of First-In-Human Clinical Trial to Evaluate HCW9302 in an Autoimmune Disease
High
Report
HCW Biologics Announces Initiation of First-In-Human Clinical Trial to Evaluate HCW9302 in an Autoimmune Disease
11/14
05:41 pm
hcwb
HCW Biologics GAAP EPS of -$2.02, revenue of $15.60M [Seeking Alpha]
High
Report
HCW Biologics GAAP EPS of -$2.02, revenue of $15.60M [Seeking Alpha]
11/14
04:44 pm
hcwb
HCW Biologics Reports Third Quarter 2025 Business Highlights and Financial Results
High
Report
HCW Biologics Reports Third Quarter 2025 Business Highlights and Financial Results
11/10
07:00 am
hcwb
HCW Biologics Shares the Latest Data for its Second-Generation Immune Checkpoint Inhibitor Presented at the 40th Annual Meeting of the Society for Immunotherapy of Cancer
Low
Report
HCW Biologics Shares the Latest Data for its Second-Generation Immune Checkpoint Inhibitor Presented at the 40th Annual Meeting of the Society for Immunotherapy of Cancer
11/7
07:00 am
hcwb
HCW Biologics Presents Preclinical Data for TRBC-Based T-Cell Engager Program at the Society for Immunotherapy of Cancer’s (SITC) 40th Annual Meeting
High
Report
HCW Biologics Presents Preclinical Data for TRBC-Based T-Cell Engager Program at the Society for Immunotherapy of Cancer’s (SITC) 40th Annual Meeting
10/22
09:00 am
hcwb
HCW Biologics Inc. (NASDAQ: HCWB) Participates in Virtual Investor “What This Means” Segment
Low
Report
HCW Biologics Inc. (NASDAQ: HCWB) Participates in Virtual Investor “What This Means” Segment